Measures of Pain Relevant to Knee Osteoarthritis

Recruiting

You are on the General Public view
  • Source

    -
    Public Title Measures of Pain Relevant to Knee Osteoarthritis
    Acronym Sorry, not currently available
    Source of Record URL http://clinicaltrials.gov/show/NCT01310257
  • Trial

    -
    Health Condition(s) or Problem Osteoarthritis of the Knee
    Lay Summary The aim is to improve understanding of the assessment of pain experience in patients with osteoarthritis (OA) of the knee. The current study will be divided into two parts. In Study 1, the investigators will analyse existing questionnaires relevant to the mechanisms and therapeutic targets of knee OA to establish discrete dimensions that discriminate between the different mechanisms of pain. On the basis of this analysis, the investigators will refine the questionnaires to maximise their sensitivity to knee OA. In Study 2, the investigators will seek to confirm the factor structure identified in the questionnaires in Study 1 and explore potential mediator and moderator variables between pain and quality of life using the refined measures. The investigators will also evaluate Quantitative Sensory Testing as a predictor of OA knee pain. (from ClinicalTrials.gov)
    Who can enter the trial Inclusion Criteria: - Participants in Study 1 will have OA of the knee defined and scored radiologically and will report knee pain. Participants in Study 2 will also have OA of the knee, but a clinical diagnosis will suffice. Exclusion Criteria: - Inability to speak or understand English - Under the age of 18 years old - knee joint surgery within three months prior to participation - Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, Gout or any other inflammatory arthritis disorder - The participants in Study 2 will also be excluded if they participated in Study 1
    Who cannot enter the trial Inclusion Criteria: - Participants in Study 1 will have OA of the knee defined and scored radiologically and will report knee pain. Participants in Study 2 will also have OA of the knee, but a clinical diagnosis will suffice. Exclusion Criteria: - Inability to speak or understand English - Under the age of 18 years old - knee joint surgery within three months prior to participation - Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, Gout or any other inflammatory arthritis disorder - The participants in Study 2 will also be excluded if they participated in Study 1
    What will happen Other; Questionnaires; Patients will be given questionnaires relevant to their condition to complete. In Study 2 and a sub-study of Study 1, patients will be invited to take part in Quantitative Sensory Testing.; Knee osteoarthritis
    Primary aim Questionnaire set assessing physical symptoms, cognitive and emotional factors, and quality of life in knee OA.
    Secondary Aim Quantitative Sensory Testing assessing pain and sensory thresholds for a noxious stimulus (Pain Pressure Thresholds); Patients will be assessed after diagnosis of OA of the knee. There is no specific time point after diagnosis, because we are interested in a broad spectrum of patients with OA of the knee.; No; Pain and sensory thresholds will be reported for the affected area (i.e., OA knee) and control areas (e.g., healthy contralateral knee).
    Participant Information Sheet Sorry, not currently available
    Website http://www.nottingham.ac.uk/paincentre/index.aspx
    Recruitment Status Recruiting
    Nation England
    Location Nottingham
  • Contact

    -
    Contact for Public Queries Bryan J Moreton, PhD 0115 846 6545 bryan.moreton@nottingham.ac.uk Bryan Moreton Principal Investigator University of Nottingham
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.